Nov 15, 2022
Say What? Decoding the Regulations Around CBD and Other Cannabinoid Claims
MJBizCon, Las Vegas, NV
The FDA has not been shy about sending enforcement letters even with a lack of regulation and guidance. Operators in the hemp-CBD/cannabinoid marketplace can limit their risk, while still being truthful and not misleading. But what exactly is that magical line businesses cannot cross before getting a Dear John from the FDA? This session will identify high-risk marketing strategies and how to adapt accordingly.
You will learn:
- Recent enforcement trends across the industry
- How to identify high-risk verbiage and example of lower-risk verbiage to communicate the same message
- What is top of mind and what the FDA is looking for when reviewing claims in testimonials, hashtags influences and Tik Tok.
- How to read enforcement actions (i.e. warning letters) and your next steps
- Q&A at the end
Session Date: Tuesday, November 15th, 2022
See the agenda here.